Andrea Necchi: MTAP loss be a potentially novel synthetic lethality target in 24% urothelial cancers

Andrea Necchi, Associate Professor at Vita-Salute San Raffaele University, shared on X/Twitter:

“By analyzing 540K pantumor samples we highlighted MTAP loss be a potentially novel synthetic lethality target in 24% urothelial cancers. Definitely worth considering for the next trial designs | Huge congrats to my team and the unique Jeff Ross.”

Source: Andrea Necchi/X